Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:72%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%-->
 +
 
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
|<!-- TITLE OF BOX -->
|<!-- TITLE OF BOX -->
Line 22: Line 23:
</div>
</div>
-
<div style="float:right; width:27%"> <!-- This margin should be right of the above -->
+
<div style="float:right; width:31%"> <!-- This margin should be right of the above -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 18:04, 3 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

EPO receptor signaling (Homo sapiens)

Image does not exist
EPO receptor signaling
Evading growth suppressors

Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer (Homo sapiens)

Image does not exist
Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer
Activating invasion and metastasis

Neural crest cell migration in cancer (Homo sapiens)

Image does not exist
Neural crest cell migration in cancer
Enabling replicative immortality

lncRNA in canonical Wnt signaling and colorectal cancer (Homo sapiens)

Image does not exist
lncRNA in canonical Wnt signaling and colorectal cancer
Inducing angiogenesis

VEGFA-VEGFR2 signaling (Homo sapiens)

Image does not exist
VEGFA-VEGFR2 signaling
Resisting cell death

PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Homo sapiens)

Image does not exist
PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer
Deregulating cellular energetics

TCA cycle nutrient use and invasiveness of ovarian cancer (Homo sapiens)

Image does not exist
TCA cycle nutrient use and invasiveness of ovarian cancer
Genome instability and mutation

Base excision repair (Homo sapiens)

Image does not exist
Base excision repair
Tumor promoting inflammation

IL6 signaling (Homo sapiens)

Image does not exist
IL6 signaling
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Image does not exist
Interferon type I signaling
Therapeutics

Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells (Homo sapiens)

Image does not exist
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools